It’s all about the money: After destroying low-cost hydroxychloroquine, Big Pharma and the complicit left-wing media are promoting Gilead’s new $3,000 drug

During the covid-19 fiasco, Big Pharma and the complicit left-wing media launched a series of media attacks against an inexpensive antiviral drug that was being used with success to help patients recover from covid-19 infections. The drug, hydroxychloroquine, had been used with success for over eighty years for various health issues. But during covid-19, a corrupt analytics company published fraudulent data that led to hydroxychloroquine being denounced in prestigious medical journals – the Lancet, and the British Medical Journal. This led health authorities in countries around the world to ditch the drug, leaving countless patients helpless. For years, this antiviral had been promoted and used for various health issues – its side effects a non-issue as people recovered from malaria and other health problems.

Big Pharma-controlled media destroys inexpensive treatments to promote expensive new drugs

Hydroxychloroquine is very inexpensive to make and, not patented, can be used for less than $20/dose. But instead of getting people the help they need, Big Pharma tried to cash in on the crisis. During the covid-19 panic, pharmaceutical companies capitalized on public health emergency orders, and secured billions of dollars in funding for new drugs and vaccines. Some of these new taxpayer-funded investments are being pushed into the market, with a steep price tag and a propaganda campaign to go along with it. Now Big Pharma and the complicit left-wing media are promoting Gilead’s new $3,120 treatment – a five-dose course of remdesivir, a formerly shelved Ebola drug.

Gilead is looking for a way to get a return on remdesivir, after the drug was originally developed to treat Ebola. Because the drug was never approved by the FDA for this use, Gilead had to shelve the drug and find a new opportunity to capitalize on it. Remdesivir has not proven effective at lowering covid-19 fatality, while inexpensive options have.

Gilead recently disclosed its outrageous price-gouging plan for remdesivir, as governments around the world prepare to place their orders. As the media hypes up remdesivir, the drug’s questionable study data remains. But the left-wing and mainstream media doesn’t care about the data on this drug; they only care about promoting the most lucrative option after they destroyed the opportunity to use hydroxychloroquine and other inexpensive treatment options. Big Pharma is very generous with the media. Big Tech is in on the swindle, too; YouTube censored a video in which medical doctors said hydroxychloroquine might help treat COVID-19.

In order to take advantage of patients, Gilead will charge $3,120 per patient. Critically ill patients will be charged $5,720 for the longer course of remdesivir. The price will be absorbed by commercial insurance in the US, leading to higher rates and deductibles – a system that makes drug companies automatically richer and more powerful. In the US, this system is especially advantageous for drug companies because the US is the only developed country where drug prices aren’t negotiated. The price is merely absorbed by health insurance plans, which continue to get more expensive each year, consuming people’s lives, ball-and-chain to a system of drug company dependence and outrageous payment plans. Government plans (Medicare and Medicaid) get a slightly lower price and hospitals receive a slight discount, but at the end of the day, drug makers dictate people’s lives, subjecting all to their most lucrative treatment plans that are literally over a hundred times more expensive than they need to be.

Why hasn’t the media or public health authorities mentioned anything people can do to strengthen their immune system? Why are time-tested anti-viral compounds dismissed in favor of highly profitable new drugs?

During covid-19, it’s more obvious than ever: Drug companies and their media acolytes aren’t interested in saving patient’s lives. They are interested in  getting the biggest return on their investment, and during a pandemic, this greedy process has put countless lives at risk and deprived people of inexpensive antivirals that could help them recover.

Sources include:

ZeroHedge.com

NaturalNews.com

NaturalNews.com

NaturalNews.com